Leveraging Existing Assets Recommendation
TOTAL SCORE: 10
Score
A1 (Feasibility increased by continuance of pandemic): 0
A2 (Necessity increased by covid pandemic): 0
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): 0
C1 (Market readiness applicability): +1
C2 (Project readiness): +1
C3 (Move to market readiness): +1
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness): +1
F (Dividends - does the recommendation aid in social activity and inclusivity?): 0
Point of comparison: The Committee’s document makes various references to digital health, but does not make explicit the potential necessary role of digital health in obtainingpreventive medicine: as a method of obtaining a minimum viable panel of market ready biomarkers. Wearable devices for example are a market ready way of continually measuring and collecting vital health information - or “digital biomarkers”.
RECOMMENDATION SUMMARY
The UK, with its network of AI centres for Health and its commitment to digital health, is a preventive medicine powerhouse, and the government’s goal can be achieved using existing preventive medicine technologies, the optimization of existing, known and validated technologies, and the emulation of best practices in preventive medicine from other countries like Singapore with the smallest gaps between life expectancy and HALE.
Score
A1 (Feasibility increased by continuance of pandemic): 0
A2 (Necessity increased by covid pandemic): 0
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): 0
C1 (Market readiness applicability): +1
C2 (Project readiness): +1
C3 (Move to market readiness): +1
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): +1
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): +1
E (Disruptiveness): +1
F (Dividends - does the recommendation aid in social activity and inclusivity?): 0
Point of comparison: The Committee’s document makes various references to digital health, but does not make explicit the potential necessary role of digital health in obtainingpreventive medicine: as a method of obtaining a minimum viable panel of market ready biomarkers. Wearable devices for example are a market ready way of continually measuring and collecting vital health information - or “digital biomarkers”.
RECOMMENDATION SUMMARY
The UK, with its network of AI centres for Health and its commitment to digital health, is a preventive medicine powerhouse, and the government’s goal can be achieved using existing preventive medicine technologies, the optimization of existing, known and validated technologies, and the emulation of best practices in preventive medicine from other countries like Singapore with the smallest gaps between life expectancy and HALE.